Annual Revenue
$37.00 K
-$20.69 M-99.82%
December 1, 2024
Summary
- As of March 12, 2025, FDMT annual revenue is $37.00 thousand, with the most recent change of -$20.69 million (-99.82%) on December 1, 2024.
- During the last 3 years, FDMT annual revenue has fallen by -$18.00 million (-99.79%).
- FDMT annual revenue is now -99.82% below its all-time high of $20.72 million, reached on December 31, 2023.
Performance
FDMT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1000.00
-$2000.00-66.67%
December 1, 2024
Summary
- As of March 12, 2025, FDMT quarterly revenue is $1000.00, with the most recent change of -$2000.00 (-66.67%) on December 1, 2024.
- Over the past year, FDMT quarterly revenue has dropped by -$4000.00 (-80.00%).
- FDMT quarterly revenue is now -100.00% below its all-time high of $20.20 million, reached on September 30, 2023.
Performance
FDMT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$37.00 K
+$20.00 K+117.65%
December 1, 2024
Summary
- As of March 12, 2025, FDMT TTM revenue is $37.00 thousand, with the most recent change of +$20.00 thousand (+117.65%) on December 1, 2024.
- Over the past year, FDMT TTM revenue has dropped by -$20.18 million (-99.82%).
- FDMT TTM revenue is now -99.84% below its all-time high of $23.02 million, reached on June 30, 2021.
Performance
FDMT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
FDMT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.8% | -80.0% | -99.8% |
| 3 y3 years | -99.8% | -100.0% | -99.8% |
| 5 y5 years | -99.5% | -100.0% | -99.8% |
FDMT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.8% | at low | -100.0% | +105.3% | -99.8% | +117.7% |
| 5 y | 5-year | -99.8% | at low | -100.0% | +100.1% | -99.8% | +117.7% |
| alltime | all time | -99.8% | at low | -100.0% | +100.1% | -99.8% | +117.7% |
4D Molecular Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $37.00 K(-99.8%) | $1000.00(-66.7%) | $37.00 K(+117.6%) |
| Sep 2024 | - | $3000.00(-40.0%) | $17.00 K(-99.9%) |
| Jun 2024 | - | $5000.00(-82.1%) | $20.22 M(-1.1%) |
| Mar 2024 | - | $28.00 K(-247.4%) | $20.45 M(-1.3%) |
| Dec 2023 | $20.72 M(+562.3%) | -$19.00 K(-100.1%) | $20.72 M(-5.8%) |
| Sep 2023 | - | $20.20 M(+8353.6%) | $21.99 M(+862.7%) |
| Jun 2023 | - | $239.00 K(-19.8%) | $2.28 M(+3.5%) |
| Mar 2023 | - | $298.00 K(-76.1%) | $2.21 M(-29.4%) |
| Dec 2022 | $3.13 M(-82.7%) | $1.25 M(+149.4%) | $3.13 M(+58.5%) |
| Sep 2022 | - | $500.00 K(+208.6%) | $1.97 M(-30.5%) |
| Jun 2022 | - | $162.00 K(-86.7%) | $2.84 M(-83.5%) |
| Mar 2022 | - | $1.22 M(+1225.0%) | $17.26 M(-4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $18.04 M(+32.5%) | $92.00 K(-93.3%) | $18.04 M(+6.3%) |
| Sep 2021 | - | $1.37 M(-90.6%) | $16.97 M(-26.3%) |
| Jun 2021 | - | $14.58 M(+629.0%) | $23.02 M(+90.6%) |
| Mar 2021 | - | $2.00 M(-304.7%) | $12.08 M(-11.3%) |
| Dec 2020 | $13.61 M(+94.8%) | -$977.00 K(-113.2%) | $13.61 M(-18.1%) |
| Sep 2020 | - | $7.42 M(+104.3%) | $16.62 M(+70.7%) |
| Jun 2020 | - | $3.63 M(+2.8%) | $9.74 M(+59.5%) |
| Mar 2020 | - | $3.54 M(+74.1%) | $6.11 M(+137.5%) |
| Dec 2019 | $6.99 M(-50.6%) | $2.03 M(+275.9%) | $2.57 M(+375.9%) |
| Sep 2019 | - | $540.00 K | $540.00 K |
| Dec 2018 | $14.13 M(+144.0%) | - | - |
| Dec 2017 | $5.79 M | - | - |
FAQ
- What is 4D Molecular Therapeutics annual revenue?
- What is the all time high annual revenue for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual revenue year-on-year change?
- What is 4D Molecular Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly revenue year-on-year change?
- What is 4D Molecular Therapeutics TTM revenue?
- What is the all time high TTM revenue for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM revenue year-on-year change?
What is 4D Molecular Therapeutics annual revenue?
The current annual revenue of FDMT is $37.00 K
What is the all time high annual revenue for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual revenue is $20.72 M
What is 4D Molecular Therapeutics annual revenue year-on-year change?
Over the past year, FDMT annual revenue has changed by -$20.69 M (-99.82%)
What is 4D Molecular Therapeutics quarterly revenue?
The current quarterly revenue of FDMT is $1000.00
What is the all time high quarterly revenue for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly revenue is $20.20 M
What is 4D Molecular Therapeutics quarterly revenue year-on-year change?
Over the past year, FDMT quarterly revenue has changed by -$4000.00 (-80.00%)
What is 4D Molecular Therapeutics TTM revenue?
The current TTM revenue of FDMT is $37.00 K
What is the all time high TTM revenue for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM revenue is $23.02 M
What is 4D Molecular Therapeutics TTM revenue year-on-year change?
Over the past year, FDMT TTM revenue has changed by -$20.18 M (-99.82%)